FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015111832> ?p ?o ?g. }

• W3015111832 endingPage "199" @default.
• W3015111832 startingPage "187" @default.
• W3015111832 abstract "Abstract Despite its efficacy in solid tumours, in particular HER2 + breast cancer, HER2‐targeted therapy has given rise to disappointing results in non‐small cell lung cancer (NSCLC). With the aim of refining the target population for anti‐HER2 therapies in NSCLC, we investigated the relationships between HER2 and the tumour suppressor fragile histidine triad (FHIT) in lung tumour cells. First, we observed a negative correlation between FHIT expression and the activated form of HER2 (pHER2) in NSCLC samples and in lung tumour cell lines. Moreover, the silencing or overexpression of FHIT in lung cell lines led to an increase or decrease of HER2 activity, respectively. We also demonstrated that two anti‐HER2 drugs, irbinitinib and trastuzumab, restore a more epithelial phenotype and counteract cell invasiveness and growth of FHIT‐silenced tumour cell lines. Finally, we showed that the FHIT low /pHER2 high phenotype predicts sensitivity to an anti‐HER2 therapy in primary tumour cells from NSCLC patients. Our results show that FHIT regulates the activity of HER2 in lung tumour cells and that FHIT‐inactivated tumour cells are sensitive to HER2 inhibitors. A new subclass of patients with NSCLC may be eligible for an anti‐HER2 therapy. © 2020 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd." @default.
• W3015111832 created "2020-04-10" @default.
• W3015111832 creator A5026022809 @default.
• W3015111832 creator A5043797392 @default.
• W3015111832 creator A5047035945 @default.
• W3015111832 creator A5051374037 @default.
• W3015111832 creator A5057798437 @default.
• W3015111832 creator A5058475585 @default.
• W3015111832 creator A5061811817 @default.
• W3015111832 creator A5063232896 @default.
• W3015111832 creator A5065711961 @default.
• W3015111832 creator A5072377541 @default.
• W3015111832 creator A5073093705 @default.
• W3015111832 creator A5080917084 @default.
• W3015111832 creator A5083503952 @default.
• W3015111832 date "2020-05-13" @default.
• W3015111832 modified "2023-10-14" @default.
• W3015111832 title "<scp> FHIT ^low </scp> / <scp> pHER2 ^high </scp> signature in non‐small cell lung cancer is predictive of <scp>anti‐HER2</scp> molecule efficacy" @default.
• W3015111832 cites W1824927203 @default.
• W3015111832 cites W1983009319 @default.
• W3015111832 cites W1983774108 @default.
• W3015111832 cites W1984098997 @default.
• W3015111832 cites W2003867647 @default.
• W3015111832 cites W2004371430 @default.
• W3015111832 cites W2005312471 @default.
• W3015111832 cites W2007010878 @default.
• W3015111832 cites W2009203565 @default.
• W3015111832 cites W2014565367 @default.
• W3015111832 cites W2016012059 @default.
• W3015111832 cites W2018654729 @default.
• W3015111832 cites W2045867270 @default.
• W3015111832 cites W2046050735 @default.
• W3015111832 cites W2046207355 @default.
• W3015111832 cites W2056637294 @default.
• W3015111832 cites W2080295298 @default.
• W3015111832 cites W2086596704 @default.
• W3015111832 cites W2093198223 @default.
• W3015111832 cites W2095253562 @default.
• W3015111832 cites W2110014936 @default.
• W3015111832 cites W2111599976 @default.
• W3015111832 cites W2133208325 @default.
• W3015111832 cites W2143946557 @default.
• W3015111832 cites W2146292887 @default.
• W3015111832 cites W2175694606 @default.
• W3015111832 cites W2239287815 @default.
• W3015111832 cites W2262992387 @default.
• W3015111832 cites W2527905628 @default.
• W3015111832 cites W2559382297 @default.
• W3015111832 cites W2606001457 @default.
• W3015111832 cites W2790561954 @default.
• W3015111832 cites W2887314183 @default.
• W3015111832 cites W2889957730 @default.
• W3015111832 cites W2901009857 @default.
• W3015111832 cites W2912993657 @default.
• W3015111832 cites W2974071678 @default.
• W3015111832 cites W2977889895 @default.
• W3015111832 doi "https://doi.org/10.1002/path.5439" @default.
• W3015111832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32237123" @default.
• W3015111832 hasPublicationYear "2020" @default.
• W3015111832 type Work @default.
• W3015111832 sameAs 3015111832 @default.
• W3015111832 citedByCount "9" @default.
• W3015111832 countsByYear W30151118322020 @default.
• W3015111832 countsByYear W30151118322021 @default.
• W3015111832 countsByYear W30151118322022 @default.
• W3015111832 countsByYear W30151118322023 @default.
• W3015111832 crossrefType "journal-article" @default.
• W3015111832 hasAuthorship W3015111832A5026022809 @default.
• W3015111832 hasAuthorship W3015111832A5043797392 @default.
• W3015111832 hasAuthorship W3015111832A5047035945 @default.
• W3015111832 hasAuthorship W3015111832A5051374037 @default.
• W3015111832 hasAuthorship W3015111832A5057798437 @default.
• W3015111832 hasAuthorship W3015111832A5058475585 @default.
• W3015111832 hasAuthorship W3015111832A5061811817 @default.
• W3015111832 hasAuthorship W3015111832A5063232896 @default.
• W3015111832 hasAuthorship W3015111832A5065711961 @default.
• W3015111832 hasAuthorship W3015111832A5072377541 @default.
• W3015111832 hasAuthorship W3015111832A5073093705 @default.
• W3015111832 hasAuthorship W3015111832A5080917084 @default.
• W3015111832 hasAuthorship W3015111832A5083503952 @default.
• W3015111832 hasBestOaLocation W30151118322 @default.
• W3015111832 hasConcept C104317684 @default.
• W3015111832 hasConcept C119056186 @default.
• W3015111832 hasConcept C121608353 @default.
• W3015111832 hasConcept C126322002 @default.
• W3015111832 hasConcept C142724271 @default.
• W3015111832 hasConcept C143998085 @default.
• W3015111832 hasConcept C1491633281 @default.
• W3015111832 hasConcept C2776256026 @default.
• W3015111832 hasConcept C2778264664 @default.
• W3015111832 hasConcept C2779786085 @default.
• W3015111832 hasConcept C2780646079 @default.
• W3015111832 hasConcept C2781230642 @default.
• W3015111832 hasConcept C2908647359 @default.
• W3015111832 hasConcept C502942594 @default.
• W3015111832 hasConcept C530470458 @default.
• W3015111832 hasConcept C54355233 @default.
• W3015111832 hasConcept C555283112 @default.

• next